This site is intended for healthcare professionals only
LoginRegister
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionSanofi, Formation Bio, OpenAI collaborate to build AI-powered software to accelerate drug...
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsBMS Gets CDSCO Panel Nod to Study Deucravacitinib
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon net profit declines 57 percent to Rs 136 crore in Q4
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 CrJohnson & Johnson to acquire Proteologix for USD 850 million in cash
USFDA Approves Corcept Therapeutics Ovarian Cancer Drug LifyorliGlenmark Pharma gets USFDA nod for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
Sun Pharma unit Taro recalls over 17k units of antifungal medication in USSun Pharma, Dr Reddy's Labs, Aurobindo recall products in US over manufacturing issues
Lupin and TB Alliance Join Forces to Advance TelacebecLupin gets 6 USFDA observations for Somerset facility
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionSubmit preliminary analysis of primary data of subjects above 18 years in India: CDSCO Panel Tells...
Windlas Biotech Gets SEC Nod to Manufacture Dapagliflozin-Pioglitazone FDCJustify Sample Size: CDSCO Panel Tells Windlas Biotech on Cardiovascular FDC
Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo NordiskCOVID vaccine: Moderna wins patent case in Europe against Pfizer, BioNTech
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and olderGSK raises USD 1.5 billion from sale of remaining Haleon stake
NPPA Finally Allows GSK to Discontinue Grisovin FPGSK Pharma declares financial results for quarter ended March 31, 2024
X